← Leaderboards
Neelam Sharma-Walia
Rosalind Franklin Univ Of Medicine & Sci
$2,876,397
Attributed
$2,876,397
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $677.4K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,876,397 · 4
By mechanism
R01$2,094,132 · 2
R21$782,265 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Kaposi Sarcoma”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$112,355,819
- Ronald T Mitsuyasu · University Of California Los Angeles$103,289,310
- David Heimbrook · Leidos Biomedical Research, Inc.$100,149,252
- Jae U Jung · Cleveland Clinic Lerner Com-Cwru$47,112,192
- Michael Shannon McGrath · University Of California San Francisco$33,859,029
- Blossom A Damania · University Of North Carolina Chapel Hill$31,849,711
Research focus
Kaposi SarcomaEndothelial CellsMulticentric Angiofollicular Lymphoid HyperplasiaHuman Herpesvirus 8Gene ExpressionViralSignal TransductionMediatingCellsEffusionPathogenesisCytokineAngiogenic FactorLytic PhaseMorbidity - Disease RateLesionLyticInflammatoryPathway InteractionsHerpesviridae InfectionsPrimary Effusion LymphomaMalignant NeoplasmsB-LymphocytesIn Vitro
Grant awards (10)
Anti-nucleolin aptamer AS1411: Applications in Kaposi's Sarcoma Associated Herpes Virus (KSHV) biology$182,325
R21 · FY2024 · CA · contact PI
Anti-nucleolin aptamer AS1411: Applications in Kaposi's Sarcoma Associated Herpes Virus (KSHV) biology$218,790
R21 · FY2023 · CA · contact PI
Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis$356,850
R01 · FY2020 · CA · contact PI
Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis$346,144
R01 · FY2019 · CA · contact PI
Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis$356,850
R01 · FY2018 · CA · contact PI
Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis$356,850
R01 · FY2017 · CA · contact PI
Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis$356,850
R01 · FY2016 · CA · contact PI
Early events of in vitro KSHV infection$320,588
R01 · FY2016 · CA · contact PI
Role of Cyclooxygenase-2 and PGE2 in KSHV pathogenesis$190,575
R21 · FY2009 · CA · contact PI
Role of Cyclooxygenase-2 and PGE2 in KSHV pathogenesis$190,575
R21 · FY2008 · CA · contact PI